Back
iShares LifePath Target Date 2040 ETF Vs. Cidara Therapeutics Industry Stock Comparison
Buy
60
ITDD
iShares LifePath Target Date 2040 ETF
Last Price:
$33.09
Seasonality Move:
7.11%
Buy
72
CDTX
Cidara Therapeutics
Last Price:
$50.58
Seasonality Move:
-8.55%
Buy
60
iShares LifePath Target Date 2040 ETF (ITDD)
is a Buy
Is iShares LifePath Target Date 2040 ETF a Buy, Sell or Hold?
-
The current iShares LifePath Target Date 2040 ETF [ITDD] share price is $33.05. The Score for ITDD is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ITDD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Cidara Therapeutics (CDTX)
is a Buy
Is Cidara Therapeutics a Buy, Sell or Hold?
-
The current Cidara Therapeutics [CDTX] share price is $50.54. The Score for CDTX is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ITDD Stock Price Chart
What is iShares LifePath Target Date 2040 ETF's stock price today?
-
The iShares LifePath Target Date 2040 ETF share price today is $33.05Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITDD is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics's stock price today?
-
The Cidara Therapeutics share price today is $50.54Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.
ITDD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.36 | Buy |
Relative Strength Index (14 RSI): | 63.48 | Buy |
Chaikin Money Flow: | -7669 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.19 - 33.01) | Buy |
Bollinger Bands (100): | (30.05 - 32.37) | Buy |
CDTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.75 | Buy |
Relative Strength Index (14 RSI): | 77.36 | Buy |
Chaikin Money Flow: | 24640 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.19 - 50.39) | Buy |
Bollinger Bands (100): | (16 - 35.28) | Buy |
ITDD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.08 | Sell |
20-day SMA: | 32.7 | Buy |
50-day SMA: | 32.02 | Buy |
200-day SMA: | 31.23 | Buy |
8-day EMA: | 20.99 | Buy |
20-day EMA: | 10.92 | Buy |
50-day EMA: | 4.9 | Buy |
200-day EMA: | 1.3 | Buy |
CDTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 49.6 | Buy |
20-day SMA: | 40.9 | Buy |
50-day SMA: | 30.03 | Buy |
200-day SMA: | 21.62 | Buy |
8-day EMA: | 49.1 | Buy |
20-day EMA: | 42.88 | Buy |
50-day EMA: | 33.88 | Buy |
200-day EMA: | 23.66 | Buy |
iShares LifePath Target Date 2040 ETF Earnings Growth & ITDD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $3.78 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.76 per share, and a decrease next year of $0.53 per share.
iShares LifePath Target Date 2040 ETF Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cidara Therapeutics Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |